Damon Meyer
11Patents
3h-index
14Co-inventors
57Inventor score
Filing activity: Sep 5, 1997 → Sep 24, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6217869A | Pretargeting methods and compounds | Chemistry; Metallurgy | 121 | Expired |
| US6359111B1 | Opioid receptor targeting | Human Necessities | 45 | Expired |
| US8871720B2 | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus | Emerging Cross-Sectional Technologies | 25 | Active |
| US10464997B2 | Selective reduction of proteins | Chemistry; Metallurgy | 3 | Active |
| US9522194B2 | Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus | Emerging Cross-Sectional Technologies | 1 | Active |
| US10391181B2 | Cyclodextrin and antibody-drug conjugate formulations | Performing Operations; Transporting | 1 | Active |
| US9987374B2 | Cyclodextrin and antibody-drug conjugate formulations | Performing Operations; Transporting | 1 | Active |
| US9453046B2 | Activated carbon filtration for purification of benzodiazepine ADCs | Chemistry; Metallurgy | 0 | Active |
| US11667696B2 | Selective reduction of proteins | Chemistry; Metallurgy | 0 | Active |
| US10457976B2 | Preparing antibodies from CHO cell cultures for conjugation | Chemistry; Metallurgy | 0 | Active |
| US9610361B2 | Cyclodextrin and antibody-drug conjugate formulations | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.